These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2108453)

  • 1. Interaction between antidepressants and d-amphetamine on variable-interval performance.
    Shah K; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1990; 100(4):548-54. PubMed ID: 2108453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DSP4 alters the effect of d-amphetamine on variable-interval performance: analysis in terms of Herrnstein's equation.
    Morley MJ; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1987; 92(2):247-53. PubMed ID: 3110849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of desipramine and fluvoxamine on timing behavior investigated with the fixed-interval peak procedure and the interval bisection task.
    Ho MY; al-Zahrani SS; Velazquez Martinez DN; Lopez Cabrera M; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1996 Jun; 125(3):274-84. PubMed ID: 8815964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of d-amphetamine on operant behaviour maintained under variable-interval schedules of reinforcement.
    Morley MJ; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1985; 87(2):207-11. PubMed ID: 3931148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation by pimozide of the suppressant effect of d-amphetamine on operant behaviour.
    Morley MJ; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1987; 91(2):239-43. PubMed ID: 3107040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxetine, a selective 5-hydroxytryptamine uptake inhibitor with antidepressant properties, lacks amphetamine-like stimulus properties in an operant drug discrimination bioassay in rodents.
    Goudie AJ; Dubicki W; Leathley M
    J Pharm Pharmacol; 1988 Mar; 40(3):192-6. PubMed ID: 2899149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine.
    Saletu B; Grünberger J; Rajna P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):369S-383S. PubMed ID: 6407499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinforcement magnitude modulation of rate-dependent effects of fluvoxamine and desipramine in the rat.
    Ginsburg BC; Lamb RJ
    Behav Pharmacol; 2008 Dec; 19(8):829-35. PubMed ID: 19020418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinforcement magnitude modulates the rate-dependent effects of fluvoxamine and desipramine on fixed-interval responding in the pigeon.
    Lamb RJ; Ginsburg BC
    Behav Pharmacol; 2008 Feb; 19(1):51-60. PubMed ID: 18195594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphetamine and LSD as discriminative stimuli: alterations following neonatal monoamine reductions.
    Minnema DJ; Rosecrans JA
    Pharmacol Biochem Behav; 1984 Jan; 20(1):95-101. PubMed ID: 6420809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine.
    Fletcher PJ
    Psychopharmacology (Berl); 1995 Mar; 118(2):155-63. PubMed ID: 7617802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action.
    Price LH; Charney DS; Delgado PL; Anderson GM; Heninger GR
    Arch Gen Psychiatry; 1989 Jul; 46(7):625-31. PubMed ID: 2500111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antidepressants on aversive periaqueductal gray stimulation in rats.
    Jenck F; Broekkamp CL; Van Delft AM
    Eur J Pharmacol; 1990 Feb; 177(3):201-4. PubMed ID: 2107091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.
    Paterson NE; Balci F; Campbell U; Olivier BE; Hanania T
    J Psychopharmacol; 2011 Oct; 25(10):1357-64. PubMed ID: 20305042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between response rate and reinforcement frequency in variable-interval schedules: III. The effect of d-amphetamine.
    Bradshaw CM; Ruddle HV; Szabadi E
    J Exp Anal Behav; 1981 Jul; 36(1):29-39. PubMed ID: 7241036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of morphine, naloxone, d,l-cyclazocine, and d-amphetamine on behaviour controlled by a schedule of interresponse time reinforcement.
    Adam-Carrière D; Merali Z; Stretch R
    Can J Physiol Pharmacol; 1978 Oct; 56(5):707-20. PubMed ID: 709412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neuroleptics and tricyclic antidepressants upon d-amphetamine discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1980 Jan; 12(1):1-5. PubMed ID: 6102768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amphetamine on behavior maintained by sucrose: interaction of reinforcement schedule and food restriction.
    Slawecki CJ; Samson HH
    Pharmacol Biochem Behav; 1996 Jul; 54(3):595-600. PubMed ID: 8743634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioural effects od d-amphetamine alone and in combination with antidepressants, antihistamines or other psychotropic drugs in young chicks.
    Schrold J
    Psychopharmacologia; 1972; 23(2):115-24. PubMed ID: 4401846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.